"With a view to contain the spread of COVID-19 following with the orders of the Government Of Tamilnadu, we are taking all necessary majors for the safety and security of all delegates."

Acute Heart Failure – Diagnostic Methods

Acute Heart Failure: Biomarkers

Acute Heart Failure: Imaging

Acute Heart Failure: Treatment

Acute Heart Failure: Pharmacotherapy

Acute Heart Failure: Non-pharmacological Treatment

Circulatory Support

Renal Replacement Therapy

Acute Heart Failure: Clinical

Coagulation and Thrombosis

Endothelial dysfunction; Clinical assessment

NASH and other ectopic lipid diseases

Chronic kidney disease and nephropathies

Diabetes; macro- and microangiopathies

Aneurysms and other non-atherosclerotic arteriopathies

Nutrition, nutraceuticals

Bariatric surgery

Lipid-lowering therapies

Anti-thrombotic therapies

Anti-inflammatory therapies

Prevention and treatment of cardiovascular disease; miscellaneous

New lipid-lowering therapies

Google Glass

Bioresorbable stents

Leadless pacemaker

Valve-in-valve procedure

Protein patch for heart muscle growth

Miniature Ventricular Assist Device

Novel Embolic Protection to Prevent Strokes

Organ Conformal Electronics

Mitral Valve Modulation and Repair

Cardiac Decellularization and Engineered Heart Tissue

Engineered Heart Valve

Artificial Intelligence to Predict Cardiac Arrhythmias

Magnetic Navigation and Robotic Systems

Pluripotent Stem Cells and Transdifferentiated Cardiomyocytes

Invasive Cardiology

Non-Invasive Cardiology

Interventional Cardiology

Coronary Intervention

Coronary Intervention: Complications

Coronary Intervention: Primary and Acute PCI

Coronary Intervention: Mechanical Circulatory Support

Coronary Intervention: Restenosis

Non-coronary Cardiac Intervention

Pharmacology and Pharmacotherapy

Cardiovascular Pharmacotherapy

Anticoagulants

Antiplatelet Drugs

Diuretics Nitrates Lipid-Lowering Agents

Anti-Diabetic Pharmacotherapy

Cardiopulmonary Physical Therapy

Cardiorespiratory Physiotherapy

Echocardiography

Intraoperative and Interventional Echocardiography

Computed Tomography

Coronary CT Angiography

Cardiac Magnetic Resonance

Nuclear Imaging

Epidemiology of cardiovascular diseases and risk factors

Epidemiology of dyslipidemias

Diabetes, insulin sensitivity and resistance

Adipose tissue homeostasis

Inherited dyslipidemias

Gender and cardiovascular risk

Environmental risk factors

Novel risk factors and biomarkers

Epidemiology of socioeconomic and psychosocial risk factors

Coagulation

Gut microbiome

Gene editing technology

Genomics, GWAS and population genetics; Mendelian randomization

Epigenetics and microRNA

Gene-Environment interactions

Arrhythmias, General

Arrhythmias, General – Treatment

Atrial Fibrillation

Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Atrial Fibrillation - Treatment

Atrial Fibrillation - Stroke Prevention

Supraventricular Tachycardia (non-AF)

Supraventricular Tachycardia (non-AF) - Pathophysiology and Mechanisms

Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome

Supraventricular Tachycardia (non-AF) - Diagnostic Methods

Supraventricular Tachycardia (non-AF) - Treatment

Supraventricular Tachycardia (non-AF) - Prevention

Supraventricular Tachycardia (non-AF) - Clinical Syncope and Bradycardia

Syncope and Bradycardia - Pathophysiology and Mechanisms

Bradycardia - AV-Block

Tachycardia

Non-arrhythmogenic Mechanisms of Syncope

Syncope and Bradycardia - Diagnostic Methods

Syncope and Bradycardia - Treatment

Drug Treatment

Pacemaker Therapy

Syncope and Bradycardia - Clinical

Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Ventricular Arrhythmias and SCD - Treatment

Management of Out of Hospital Cardiac Arrest

Device Treatment of Ventricular Arrhythmias and SCD

Ventricular Arrhythmias and SCD - Clinical

Device Therapy Device Complications and Lead Extraction

HEART–Access to Care/Caregiver

HEART–Basic Science-Immunology, Inflammation

HEART–Basic Science-Models of Organ Preservation, Perfusion and Graft Injury

HEART–Basic Science-Translational Research/Other

HEART–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs

HEART–Cardiac Allograft Vasculopathy

HEART–Cardiogenic Shock

HEART–Clinical Ex-Vivo Perfusion and Preservation

HEART–Compliance/Adherence/Psychosocial Aspects

HEART–Complications Other

HEART–Congenital Heart Disease Management

HEART–COVID 19 Vaccine Pre- and Post-Transplant

HEART–COVID-19 Non-Vaccine related

HEART–Critical Care Medicine/Peri-operative/Intra-operative Management

HEART–Diagnostics/Patient Management/Patient Care Pathways

HEART–Donor Management HEART–Economics, Ethics, Public Policy/Health Equity

HEART–Immunology, Inflammation (Clinical)

HEART–Infectious Diseases - Diagnostics and Complications

HEART–Infectious Diseases - Management and Therapeutics

HEART–Organ Allocation HEART–Other (Clinical)

HEART–Outcomes (Effectiveness)

HEART–Outcomes (Other)

HEART–Outcomes (Risk Prediction/Modelling)

HEART–Outcomes (Safety)

HEART–Palliative Care/Self Care/Symptom Management

HEART–Pathology

HEART–Patient Selection for Advanced Therapies/Rehabilitation

HEART–Pediatrics-Basic and Translational Research

HEART–Pediatrics-Complications

HEART–Pediatrics-Heart Failure

HEART–Pediatrics-Other

HEART–Pediatrics-Outcomes

HEART–Pediatrics-Patient Selection, Organ Allocation, Donor Management

HEART–Pharmacology, Therapeutics, Immunosuppression

HEART–Primary Graft Dysfunction

HEART–Quality of Life/Quality Improvement

HEART–Rejection-Antibody Mediated (AMR)

HEART–Rejection-Cellular

HEART–Telehealth/Remote Monitoring and Interventions

Hypertrophic Cardiomyopathy

Dilated Cardiomyopathy

Restrictive Cardiomyopathy

Arrhythmogenic Right Ventricular Dysplasia

Alcoholic cardiomyopathy

Congestive cardiomyopathy

Diabetic cardiomyopathy

Familial dilated cardiomyopathy

Idiopathic cardiomyopathy

Ischemic cardiomyopathy

Peripartum cardiomyopathy

Primary cardiomyopathy

Asymmetric septal hypertrophy

Familial hypertrophic cardiomyopathy

Hypertrophic nonobstructive cardiomyopathy

Hypertrophic obstructive cardiomyopathy

Idiopathic hypertrophic subaortic stenosis

Idiopathic restrictive cardiomyopathy

Infiltrative cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy

Right ventricular cardiomyopathy

Right ventricular dysplasia

Aortic Surgery

Cardiac Surgery and Arrhythmias

Cardiac Surgery and CHD and Pediatrics

Cardiac Surgery and Heart Failure

Cardiac Surgery and SIHD

Cardiac Surgery and VHD

Vascular Surgery

Coronary artery bypass grafting (CABG)

Heart valve repair or replacement

Insertion of a pacemaker or an implantable cardioverter-defibrillator (ICD).

Maze surgery

Aneurysm repair

Insertion of a ventricular assist device (VAD) or total artificial heart (TAH)

Abdominal Surgery

Experimental Surgery

Discuss COVID-19 in diabetes and Obesity

Describe the relationship between diabetes, obesity, and heart failure

Discuss T1D obesity and CVD

Discuss the role of the beta cells in diabetes

Discuss the role of fat cells in the development of cardiometabolic conditions

Explain the roles of diabetes in the development of micro & macrovascular conditions: kidney disease, retinopathy, neuropathy, CVD, and strokes

Provide the traditional comprehensive management of diabetes, addressing obesity, hypertension, dyslipidemia, and hyperglycemia

Highlight the paradigm shift in management focusing on preventing the next evet of ASCVD, HF and CKD

Discuss the role of GLP1ra in the management of diabetes, obesity, and prevention of ASCVD

Evaluate SGLT2 inhibitors role in reducing cardiovascular morbidity & mortality in patients with and without T2D and at risk for or established CVD

Address SGLT2i role in managing patients with CKD and HFrEF & HFpEF

Explain the role of PCSK9 inhibitors in preventing CV morbidity in people with established ASCVD

Discuss fatty liver disease and its relationship to diabetes and CVD

Evaluate the impact on the clinical practice of lipid CV outcome trials, including IMPROVE-IT, FOURIER, REDUCE-IT, ODYSSEY-Outcomes

Examine the impact of Coagulation in diabetes in prevention of CVD and CVA

Technology in monitoring and reducing DM & ASCVD

Address the multispecialty practice recommendations to managing patients with cardiorenalmetabolic diseases